Screenome™ is Virotek’s most comprehensive genomic screening platform that integrates a full suite of clinically actionable reports into a single test, enabling personalized prevention, early risk detection, and proactive health management.
Order Test
Individuals interested in a one-time test that serves as a lifelong health resource.
Patients with multiple prescriptions, unexplained medical conditions, or who are not responding to current treatments.
Those with family histories of disease where clear hereditary patterns have not been identified.
Healthcare professionals offering high-end preventive health programs requiring genomic risk profiling.
Built on four pillars of genetic risk—hereditary cancer, rare disease, polygenic risk, and medication response—Screenome™ integrates HerCan-TEK+, Heredi-TEK, PRS-TEK, and Pill-TEK into four comprehensive reports.
77-gene hereditary cancer panel
84 ACMG-recommended genes
19 common disease risks
200+ medication response
A Lifelong Resource: Provides relevant genomic insights that can be used by healthcare providers across different clinical contexts over a lifetime.
The Most Complete View: Unlike standard panels, Screenome™ captures both monogenic and polygenic disease risk for complex health conditions.
Actionable Insights: Our reports provide a roadmap for preventive care, early diagnosis, and personalized treatment strategies.
Screenome™ provides clinicians with a high-depth genomic foundation to guide lifelong patient management.
Scope: Whole genome sequencing with targeted enrichment capable of identifying SNVs, indels, and CNVs.
Actionability: Focused on clinically validated, guideline-anchored variants from accredited clinical guidelines.
Integration: Designed to be incorporated into baseline checkups or specialized preventive health programs.
A simple, guided process from consultation to clinically actionable reporting.
Contact our team to learn how our tests can enhance your clinical offerings and improve patient outcomes.
Contact Sales Request Information